Greenstar Biosciences (GTSIF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF) - Psyched: MindMed's 2020 Financials, Psychedelics ETF Rebalancing, Country's First Psychedelics Masters Degree
MindMed (OTCQB:MMEDF) released its full-year 2020 financial results. The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the reporting period were $85.6 million, counting $80.1 million in cash. The company used $24.2 million of net cash in operating activities in 2020. Its cash balance as of Tuesday last week hovered at $161 million. The company plans to use the money to improve its portfolio and develop its technology sector. On Monday, MindMed also revealed the results of a study on personalized MDMA dosing, con...
Source: benzinga.com